RT Journal Article
SR Electronic
T1 mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.13.21262182
DO 10.1101/2021.09.13.21262182
A1 Tahir Kafil
A1 Mariana M Lamacie
A1 Sophie Chenier
A1 Heather Taggart
A1 Nina Ghosh
A1 Alexander Dick
A1 Gary Small
A1 Peter Liu
A1 Rob S Beanlands
A1 Lisa Mielniczuk
A1 David Birnie
A1 Andrew M Crean
YR 2021
UL http://medrxiv.org/content/early/2021/09/24/2021.09.13.21262182.abstract
AB During the process of open peer review on MedRxiv we quickly received a number of messages from reviewers concerned that there was a problem with our reported incidence of myocarditis post mRNA vaccination. Our reported incidence appeared vastly inflated by an incorrectly small denominator (ie number of doses administered over the time period of the study). We reviewed the data available at Open Ottawa and found that there had indeed been a major underestimation, with the actual number of administered doses being more than 800,000 (much higher than quoted in the paper).In order to avoid misleading either colleagues or the general public and press, we the authors unanimously wish to withdraw this paper on the grounds of incorrect incidence data. We thank the many peer reviewers who went out of their way to contact us and point out our error. We apologize to anyone who may have been upset or disturbed by our report.In summary, the authors have withdrawn this manuscript because of a major error pertaining to the quoted incidence data. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Ottawa Heart Institute IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes